Table 2. Demographic and clinical characteristics of the groups.

Parameters	Patient group (n = 32)	Control group (n = 22)	p-value
Mean age (years)	50 ± 9	51 ± 10	0.979
Gender M/F	15/17	11/11	0.821
Body mass index (kg/m²)	29.8 ± 3.4	28.2 ± 3.2	0.094
Smoking, n (%)	5 (15)	7 (31)	0.160
Hypertension, n (%)	6 (18)	6 (27)	0.459
Diabetes mellitus n (%)	4 (12)	3 (13)	0.903
Dyslipidaemia, n (%)	11 (34)	5 (22)	0.357
Glucose (mg/dl)	105.4 ± 21.4	102.8 ± 28.9
(mmol/l)	5.85 ± 1.19	5.71 ± 1.60	0.174
AST (U/l)	25.7 ± 6.9	25.2 ± 7.4	0.711
ALT (U/l)	28.5 ± 12.1	26.1 ± 12.2	0.459
LDH (U/l)	159.5 ± 21.7	156.3 ± 17.8	0.672
Haemoglobin (g/dl)	14.1 ± 1.1	13.8 ± 1.3	0.622
Total cholesterol (mg/dl)	200.7 ± 40.3	184.3 ± 40.3	0.119
(mmol/l)	5.20 ± 1.04	4.77 ± 1.04
Triglyceride (mg/dl)	184 ± 85.5	158.4 ± 77.9	0.189
(mmol/l)	2.08 ± 0.97	1.79 ± 0.88
High-density lipoprotein (mg/dl)	40 ± 8.8	39.5 ± 11.2	0.433
(mmol/l)	1.04 ± 0.23	1.02 ± 0.29
Low-density lipoprotein (mg/dl)	124.7 ± 35	113.4 ± 35.8	0.144
(mmol/l)	3.23 ± 0.91	2.94 ± 0.93

AST: aspartate aminotransferase, ALT: alanine transaminase, LDH: lactate dehydrogenase.